Tiziana Life Sciences Ltd (TLSA) stock
TLSANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.58+0.01 (+1.75%)
Close on Nov 16, 2026Market cap $69.89MP/E –Yield –
Tiziana Life Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$12.85M. The highest annual figure on record is -$1.53M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$12.85M | – |
| FY2024 | Dec 31, 2024 | -$1.53M | – |
| FY2023 | Dec 31, 2023 | -$15.70M | – |
| FY2022 | Dec 31, 2022 | -$19.62M | – |
| FY2021 | Dec 31, 2021 | -$21.76M | – |
| FY2020 | Dec 31, 2020 | -$11.34M | – |
| FY2019 | Dec 31, 2019 | -$6.80M | – |
| FY2018 | Dec 31, 2018 | -$4.60M | – |
| FY2017 | Dec 31, 2017 | -$7.53M | – |
See a number that looks wrong?